You are leaving this website and being redirected. The links below are neither owned nor controlled by Jazz. Jazz is not responsible for the content of any third-party sites.
For information for those in the UK click here to view the Vyxeos Liposomal (daunorubicin/cytarabine) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in Northern Ireland click here to view the Vyxeos Liposomal (daunorubicin/cytarabine) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in the Republic of Ireland click here to view the Vyxeos Liposomal (daunorubicin/cytarabine) Patient Information Leaflet on the EMA (European Medicines Agency) website.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ (United Kingdom including Northern Ireland). For the Republic of Ireland, reporting forms and information can be found at: https://www.hpra.ie/homepage/about-us/report-an-issue
By reporting side effects, you can help provide more information on the safety of this medicine.
UK-VYX-2200162 | November 2022